Journal of Thrombosis and Haemostasis

Cover image for Vol. 14 Issue 4

Edited By: Pieter Reitsma and Frits Rosendaal

Impact Factor: 5.72

ISI Journal Citation Reports © Ranking: 2014: 6/60 (Peripheral Vascular Disease); 7/68 (Hematology)

Online ISSN: 1538-7836

Recently Published Issues

See all

Special Issues from JTH

Special Issues from JTH

Now available! The new 2015 State of the Art issue from Journal of Thrombosis and Haemostasis (JTH)™, the definitive collection of topical reviews in thrombosis and hemostasis written by internationally acclaimed experts in the field. Access is free to this issue!

State of the Art

Compilations from JTH

JTH Compilations

Read now, a new Women's Health Compilation of popular JTH articles on the subject of women's health published since 2010!

Womens Health

Available Now, a Hemophilia Compilation of the most popular manuscripts on the subject of hemophilia published in JTH since 2010. Explore the table of contents and discover the important research published on this topic in JTH!

Hemophilia Compilation

Also available, a Direct Oral Anticoagulants Compilation


For the latest news, please follow the Editors on Twitter:


Try our new JTH App for the iPhone and iPad!


Click here to learn more and download free!

This Month in JTH

Cartoon representations of the effect of heparin and GPIbα, and SbO4L, following binding to exosite 2 of thrombin


There are two Review articles in the April issue. The first is on thrombin activatable fibrinolysis inhibitor and summarizes what is known about its structure and how this impacts function. The second review discusses ITAM receptors, their associated signaling pathways in platelets, and how this relates to vascular function in development and in inflammation. The In Focus article, as usual accompanied by a Commentary, is also on platelets, and examines in mechanistic detail, how E. coli induces platelet aggregation. The final pick is a deep biochemistry study of von Willebrand factor. It examines the details of O-glycosylation and the results provide a new starting point for studies into the influence of this type of glycosylation on functional aspects of von Willebrand factor.


Structure-function relationships in thrombin-activatable fibrinolysis Inhibitor

Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development


How can non-nucleated platelets be so smart?

In Focus
Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner


Site-specific analysis of von Willebrand factor O-glycosylation

Top Reasons to Submit Your Research to Journal of Thrombosis and Haemostasis (JTH)

Submit to JTH

• High 2014 Impact Factor: 5.720
• Rapid publication of Accepted Articles online, ahead of print and before copy-editing
• Publication of final articles in Early View, ahead of print
• Easy online submission at
• Prime exposure to all ISTH members and international experts in the field
• Join the ranks of top cited and most read researchers publishing in this authoritative publication
• Submission to first decision of 19 days

Yet another benefit when you choose to publish in JTH™!

JTH™ supports authors by posting the accepted versions of articles by NIH grant-holders to PubMed Central upon acceptance by the journal. We do this automatically for you.

Read the full details on our policy regarding the deposit of articles for research funded by the NIH in the mandate that became effective on 7 April 2008.

Journal and ISTH News

Journal and Society from JTH

ISTH Membership. To ensure that you receive continued access to the JTH, renew your ISTH membership. Get started today.

Click to read JTH's new article: Global public awareness of venous thromboembolism

The first World Thrombosis Day, led by the ISTH, was on October 13, 2014, and was marked with the JTH Open Access article titled, “Thrombosis: a major contributor to the global disease burden.” To read the article, click on the image below.

READ NOW Thrombosis: a major contributor to the global disease burden